Evidence map›Paper›PMID 17376899›Full record

ArticleJournal of virology2007

Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination.

Vijayakumar Velu, Sunil Kannanganat, Chris Ibegbu, Lakshmi Chennareddi, Francois Villinger, Gordon J Freeman, Rafi Ahmed, Rama Rao Amara

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. CD8Frontiers in immunology · 2019
    Review
  17. Article
  18. Article
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vijayakumar VeluVaccine Research Center, Department of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia 30329, USA.
Sunil Kannanganat
Chris Ibegbu
Lakshmi Chennareddi
Francois Villinger
Gordon J Freeman
Rafi Ahmed
Rama Rao Amara
Emory National Primate Research CenterDana-Farber Cancer Institute · USEmory University · US

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Transgenic/KnockoutP01AI056299 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SHARPE, ARLENE H. · 2003 to 2023
$42.5M
Preclinical trialsP01AI049364 · NIAID · EMORY UNIVERSITY · PI ROBINSON, HARRIET L · 2001 to 2005
$12.8M
CD4 Immune Reconstitution in SIV InfectionR01HL075833 · NHLBI · EMORY UNIVERSITY · PI VILLINGER, FRANCOIS J. · 2003 to 2007
$2.6M
Poxvirus Immunity and DNA/MVA HIV VaccinesR01AI057029 · NIAID · EMORY UNIVERSITY · PI AMARA, RAMA RAO · 2003 to 2007
$2.1M
NCRR NIH HHS P51 RR000165NCRR NIH HHS P51 RR00165NHLBI NIH HHS R01 HL075833NIAID NIH HHS AI56299NIAID NIH HHS P01 AI049364NIAID NIH HHS P01 AI056299NIAID NIH HHS P01 AI49364NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI50409NIAID NIH HHS R01 AI057029NIAID NIH HHS R01 AI57029
6 · The paper itself

Abstract

Here, we study the temporal expression of the inhibitory receptor programmed death 1 (PD-1) on simian immunodeficiency virus (SIV) Gag-specific T cells following pathogenic SIV infection or following vaccination with a DNA/modified vaccinia virus Ankara (DNA/MVA) vaccine and simian/human immunodeficiency virus (SHIV) challenge in macaques. Following infection, the majority (>95%) of Gag-specific CD8 T cells expressed PD-1, and the level of PD-1 expression per cell increased over time. The level of PD-1 expression in lymph nodes and rectal mucosal tissue, the major sites of virus replication, was higher compared to blood. In vitro blockade of PD-1 resulted in enhanced proliferation of SIV-specific CD8 as well as CD4 T cells. In contrast, following vaccination, the majority of peak effector Gag-specific CD8 T cells expressed low levels of PD-1, and these levels decreased further as the cells differentiated into memory cells. In addition, following SHIV challenge of these vaccinated macaques, the level of PD-1 expression on Gag-specific CD8 T cells correlated positively with plasma viremia. These results demonstrate that SIV-specific CD8 T cells express PD-1 after exposure to antigen but downregulate expression under conditions of antigen clearance and enhance expression under conditions of antigen persistence. They also demonstrate that the level of PD-1 expression per cell rather than the presence or absence of expression plays an important role in regulating CD8 T-cell dysfunction in pathogenic SIV infection. In addition, they demonstrate that similar to HIV infection, the PD-1:PD-1 ligand inhibitory pathway is operational in pathogenic SIV infection, and the macaque/SIV model would be ideal to test the safety and therapeutic benefit of blocking this pathway in vivo.

Indexed as

AnimalsAntibodies, BlockingAntigens, CDApoptosis Regulatory ProteinsCD8-Positive T-LymphocytesCells, CulturedChronic DiseaseEpitopes, T-LymphocyteGene Expression Regulation, ViralMacaca mulattaReceptors, ImmunologicSAIDS VaccinesSignal TransductionSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAntibodies, BlockingAntigens, CDApoptosis Regulatory ProteinsEpitopes, T-LymphocyteReceptors, ImmunologicSAIDS Vaccines

Identifiers

PMID17376899
PMCPMC1900286
OpenAlexW2157199182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.